the formation of neurofibrillary tangles and alterations in the amyloid metabolism, causing synaptic loss and neuronal death 1, 2 . The etiology of AD is still considered complex and undefined, despite the progress made in the understanding of its biochemical and genetic mechanisms 3, 4 . Genetic studies have highlighted four genes responsible for AD: amyloid precursor protein, presenilin-1, presenilin-2 and apolipoprotein E 5 .
Cytogenetic analyses in patients diagnosed with AD have demonstrated a significant increase in numerical chromosomal alterations in different cell types of these patients 6 . Subsequent studies have also shown numerical chromosomal alterations related to the X chromosome, indicating a characteristic to be evaluated in these patients 7, 8, 9 . To date, there is no cytogenetic information available about patients with AD in the state of Amazonas, Brazil. The genes associated with AD have already been chromosomally mapped. The apolipoprotein E gene is located on chromosome 19q13.32, the presenilin-1 gene on chromosome 14q24.2, the presenilin-2 gene on chromosome 1q42.13 and the amyloid precursor protein gene is located on chromosome 21q21.3 10, 11, 12 .
Accordingly, the aim of this study was to perform cytogenetic analyses in nine patients diagnosed with AD, as well as in nine healthy individuals, attending the University Hospital Getúlio Vargas Outpatient Clinic Araújo Lima in Manaus, Amazonas, Brazil. Conventional cytogenetic markers (conventional staining and G-banding) were used to investigate the presence of chromosomal alterations in peripheral blood lymphocytes and to verify whether there was a high frequency of these alterations in AD patients of Manaus.
METHODS
The study was approved by the Research Ethics Committee of the Amazonas State University, under the authorization number 2.456.885 (CAAE: 66630616.6.0000.5016). The individuals studied were referred by doctor Talísia Vianez from the Department of Neurology at the University Hospital Getúlio Vargas Outpatient Clinic Araújo Lima. The cohort included nine individuals (one man and eight women), aged between 62 and 85 years, who had previously been diagnosed with AD, for at least three years; and nine healthy individuals (control group, one man and eight women) of the same age group. The purpose of the research was explained to all patients, and all signed the Informed Consent Term, as required by the National Health Council. All the patients were submitted to the Mini-Mental State Examination (MMSE) to evaluate their cognitive functions 13 . The MMSE scores were used to classify the cognitive impairment of the patients into three levels: 24-30 = no cognitive impairment; 18-23 = mild cognitive impairment; and 0-17 = severe cognitive impairment 14 .
Cytogenetic analyses were performed at the Laboratory of Cytogenetics of the Amazonas State University. Metaphase mitotic chromosomes were obtained from lymphocyte culture 15 . G-banding was obtained using trypsin solution 16 . Metaphases were karyotyped using the GeneALL program, and the chromosomal alterations were classified according to the International System for Human Cytogenetic Nomenclature.
RESULTS
The characteristics of the AD patients (age, MMSE test scores and diagnosis year) and the chromosomal alterations found in these patients are shown in the Table. Based on MMSE scores, eight patients were in the category of severe cognitive impairment (0-17 points), of whom two did not score any points; and one patient was in the category of mild cognitive impairment (18-21 points).
A total of 100 metaphases were analyzed from each AD patient and individual in the control group. Among the nine patients of the AD group, only one (B-09) did not have metaphases with chromosomal alterations (2n = 46,XX; Figure  1A ). The other eight showed metaphases with numerical chromosomal alterations related to the loss of one of the X chromosomes (2n = 45,X), as well as with the concomitant loss of a X chromosome and an autosomal chromosome (2n = 4,X,-X,-10; 2n = 44,X,-X,-13 and 2n = 44,X,-X,-21) ( Figure B , C). Chromosomal aneuploidies identified in the AD group were classified as X chromosome aneuploidy and double aneuploidy (loss of one X chromosome and autosomes) (Table) . In the control group, all individuals underwent the same process of chromosomal analysis and no chromosomal alterations were found in their karyotypes.
DISCUSSION
Alzheimer's disease is a chronic neurodegenerative disorder, which compromises cognitive functions and the individual's behavior, social and professional life 17 . Chromosome studies in AD patients have shown the presence of chromosomal alterations, as well as a high frequency of these changes in the karyotypes of patients with AD, suggesting that these alterations may be associated with the disease 18, 19, 20 .
Chromosomal alterations of aneuploid type in AD patients have been reported in the different cell types, suggesting that there is a systemic chromosome instability in AD. In the neuronal cells in AD patients, aneuploidy potentially contributes to functional decline and predisposition to the disease, and a two-fold increase in X chromosome aneuploidy rates has been shown in neural cells of the hippocampus and cerebrum, which are dramatically affected by neurodegeneration 9 . Non-neural cells (peripheral blood lymphocyte cells, buccal cells and fibroblast tissue) were isolated from AD patients and showed increased aneuploidy X chromosome and autosomal chromosomes 21 . Chromosome instability results in loss or gain of chromosome in different cells and tissue as well as harmful effects on organism physiology, and is considered a risk factor for AD neuropathogenesis 21, 22 .
Cytogenetic analyses performed in the present study with patients diagnosed with AD revealed that only one patient did not show any numerical and/or structural chromosomal alterations (2n = 46,XX). On the other hand, the presence of aneuploidies was observed in the karyotypes of eight patients diagnosed with AD (2n = 45,X), which corroborates the literature data available for other localities 7, 8, 9 . When comparing these results with the healthy elderly, no type of chromosomal alteration was observed, presenting with only normal metaphase cells (46,XX and 46,XY). This demonstrates that these alterations are associated with AD, which seems to favor the loss of one of the X chromosomes and one of the autosomal chromosomes (chromosomes 10, 13 and 21). This is the first record of chromosomal alterations in AD patients of the state of Amazonas. The X chromosome contains some genes that are associated with the nervous system. Chromosomal syndromes resulting from the loss of X can influence the cognitive capacity of the individual, and intellectual deficiency is the main characteristic of these syndromes 23, 24 . Karyotype analysis performed in patients with non-Down syndrome intellectual disability, attending the APAE-Manaus, identified one patient with mosaic Turner syndrome (45,X/46,XX) detected by classical cytogenetics, demonstrating a correlation between the loss of X chromosome and intellectual deficiency 25 . Although a relationship between X chromosome loss and cognitive/intellectual impairment in certain diseases is evident, in the present study, no direct evidence of a correlation between the X chromosome loss and the degree of cognitive impairment (MMSE test) was found in AD patients. There was also no association between chromosomal loss and age or time to diagnosis, which emphasizes the need for complementary studies.
Several authors have suggested that the relatively high frequency of chromosomal alterations was not necessarily related to AD itself, but rather to aging 7, 26 . Alzheimer's disease is a systematic disease that accelerates aging. It has been proposed that the X chromosome may underlie the instability of the AD cell genome, leading to a significant level of aneuploidy and a high percentage of premature centromere division 27, 28 . Premature centromere division is one of the cellular events that causes loss of the control of the segregation of the centromeres, contributing to the emergence of chromosomal alterations 28, 29 . Furthermore, the concomitant loss of one of the sex chromosomes (X chromosome) and one of the autosomal chromosomes (one of the homologues of the chromosome pairs 10, 13 and 21) has been described in AD patients for the first time. Double aneuploidies (gain or loss of two or more chromosomes) have been rarely reported in the literature. The mechanism underlying the origin of double aneuploidy is unclear. It has been hypothesized that double aneuploidy results either from two nondisjunctional events in gametogenesis or from a single nondisjunctional event in a trisomic zygote 30, 31 . Regarding the autosomal chromosomes, one of the main genes involved in AD, the amyloid precursor protein gene, is located on chromosome 21 32 . Amyloid precursor protein is directly linked to AD pathogenesis, and it was one of the first genes to be associated with chromosomal alterations. Down syndrome patients (chromosome 21 trisomy), who usually manifest this neuropathology around the age of 40 years, have a greater expression of the amyloid precursor protein gene 33, 34, 35 . It is worth mentioning that aneuploidy of other types of autosomes (1, 7, 11, 14, 17 and 18) has also been reported in AD patients, indicating a significant increase in aneuploidies of autosomal chromosomes 9, 17 .
In conclusion, the results of the present study, together with literature data, indicate that the karyotypes of patients diagnosed with AD go through different levels of chromosomal alterations, reinforcing the importance of the use of cytogenetic analyses (cytogenetic markers) in medical trials. Additional studies are needed to understand the implications of the loss of X chromosomes involved in patients with Alzheimer's disease in Manaus, Amazonas, Brazil.
